Table Of Contents

1. Introduction 30
1.1. Objectives Of The Study 30
1.2. Market Definition 30
1.3. Overview Of Global Skin Graft Market 30
1.4. Currency And Pricing 31
1.5. Limitation 31
1.6. Markets Covered 32
2. Market Segmentation 34
2.1. Markets Covered 34
2.2. Geographic Scope 35
2.3. Years Considered For The Study 36
2.4. Currency And Pricing 36
2.5. Research Methodology 37
2.6. Primary Interviews With Key Opinion Leaders 40
2.7. Secondary Sources 41
2.8. Assumptions 41
3. Market Overview 42
3.1. Drivers 44
3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers And Skin Infections 44
3.1.2. Technological Advancements And Developments In Skin Grafting Techniques 45
3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure 46
3.2. Restraints 47
3.2.1. Side Effects Related To The Skin Graft Procedure 47
?
3.3. Opportunities 48
3.3.1. Increasing Medical Tourisms 48
3.4. Challenges 49
3.4.1. Competition Among Major Players 49
4. Executive Summary 50
5. Premium Insights 53
6. Global Skin Graft Market, By Type 56
6.1. Overview 57
6.2. Autologous 59
6.3. Isogeneic 60
6.4. Allogeneic 61
6.5. Xenogeneic 62
6.6. Prosthetic 63
7. Global Skin Graft Market, By Graft Thickness 64
7.1. Overview 65
7.2. Split-Thickness 67
7.3. Full-Thickness 68
7.4. Composite Graft 69
8. Global Skin Graft Market, By Application 70
8.1. Overview 71
8.2. Burns 73
8.3. Extensive Wound 74
8.4. Extensive Skin Loss Due To Infection 75
8.5. Skin Cancer 76
?
9. Global Skin Graft Market, By Equipment Type 77
9.1. Overview 78
9.2. Dermatome 80
9.2.1. Knife Dermatomes 82
9.2.1.1. Blair/Brown Knife 83
9.2.1.2. Watson Knife 83
9.2.1.3. Cobbett Knife 83
9.2.2. Drum Dermatomes 84
9.2.2.1. Padgett Dermatomes 84
9.2.2.2. Reese Dermatomes 85
9.2.3. Electrical Dermatomes 85
9.2.4. Air-Powdered Dermatomes 86
9.3. General Surgical Instruments 87
9.4. Consumables 88
9.5. Others 89
10. Global Skin Graft Market, By End User 90
10.1. Overview 91
10.2. Hospitals 93
10.3. Dermatology Clinics 94
10.4. Ambulatory Surgical Centers 95
11. Global Skin Graft Market, By Geography 96
11.1. Overview 97
11.2. North America 104
11.2.1. U.S. 115
11.2.2. Canada 119
11.2.3. Mexico 123
?
11.3. Europe 128
11.3.1. Germany 139
11.3.2. France 143
11.3.3. U.K. 147
11.3.4. Italy 151
11.3.5. Spain 155
11.3.6. Switzerland 159
11.3.7. Netherlands 163
11.3.8. Belgium 167
11.3.9. Russia 171
11.3.10. Turkey 175
11.3.11. Rest Of Europe 179
11.4. Asia-Pacific 180
11.4.1. China 191
11.4.2. Japan 195
11.4.3. India 199
11.4.4. South Korea 203
11.4.5. Australia 207
11.4.6. Singapore 211
11.4.7. Thailand 215
11.4.8. Malaysia 219
11.4.9. Indonesia 223
11.4.10. Philippines 227
11.4.11. Rest Of Asia-Pacific 231
11.5. South America 232
11.5.1. Brazil 243
11.5.2. Rest Of South America 247
?
11.6. Middle East & Africa 248
11.6.1. South Africa 259
11.6.2. Rest Of Middle East & Africa 263
12. Global Skin Graft Market, Company Landscape 264
12.1. Company Share Analysis; Global 264
12.2. Company Share Analysis; North America 265
12.3. Company Share Analysis; Europe 266
12.4. Company Share Analysis; Asia-Pacific 267
13. Company Profiles 268
13.1. Integra Lifesciences Corporation 268
13.1.1. Company Overview 268
13.1.2. Integra Lifesciences Corporation; Revenue Analysis 269
13.1.3. Product Portfolio 270
13.1.4. Recent Developments 271
13.2. Organogenesis Inc. 272
13.2.1. Company Overview 272
13.2.2. Organogenesis Inc.; Company Snapshot 272
13.2.3. Product Portfolio 273
13.2.4. Recent Developments 273
13.3. Zimmer Biomet 274
13.3.1. Company Overview 274
13.3.2. Zimmer Biomet; Revenue Analysis 274
13.3.3. Product Portfolio 275
13.3.4. Recent Developments 276
13.4. B. Braun Melsungen Ag 277
13.4.1. Company Overview 277
13.4.2. B. Braun Melsungen Ag; Revenue Analysis 277
13.4.3. Product Portfolio 278
13.4.4. Recent Developments 278
13.5. Avita Medical 279
13.5.1. Company Overview 279
13.5.2. Avita Medical; Revenue Analysis 279
13.5.3. Product Portfolio 280
13.5.4. Recent Developments 280
13.6. De Soutter Medical 281
13.6.1. Company Overview 281
13.6.2. De Soutter Medical; Company Snapshot 281
13.6.3. Product Portfolio 281
13.6.4. Recent Developments 281
13.7. Exsurco Medical, Inc. 282
13.7.1. Company Overview 282
13.7.2. Exsurco Medical, Inc.;Company Snapshot 282
13.7.3. Product Portfolio 283
13.7.4. Recent Developments 283
13.8. Mallinckrodt 284
13.8.1. Company Overview 284
13.8.2. Mallinckrodt; Revenue Analysis 284
13.8.3. Product Pipeline 285
13.8.4. Recent Developments 285
13.9. Nouvag 286
13.9.1. Company Overview 286
13.9.2. Nouvag; Company Snapshot 286
13.9.3. Product Portfolio 286
13.9.4. Recent Developments 286
?
13.10. Surtex Instruments Limited 287
13.10.1. Company Overview 287
13.10.2. Surtex Instruments Limited; Company Snapshot 287
13.10.3. Product Portfolio 288
13.10.4. Recent Developments 288
13.11. Tissue Regenix 289
13.11.1. Company Overview 289
13.11.2. Tissue Regenix; Revenue Analysis 289
13.11.3. Product Portfolio 290
13.11.4. Recent Developments 290
14. Related Reports 291

?